Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.19 EUR
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:00 PM 02/3/15 All times are local (Market data is delayed by at least 15 minutes).

uluru inc (OXX1) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ULURU INC (OXX1)

Related News

No related news articles were found.

uluru inc (OXX1) Related Businessweek News

No Related Businessweek News Found

uluru inc (OXX1) Details

ULURU Inc., a specialty pharmaceutical company, is engaged in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company develops its products based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as non-healing surgical, trauma, and chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; Aphthasol for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company’s OraDisc products are also used for various dental applications. ULURU Inc. is headquartered in Addison, Texas.

7 Employees
Last Reported Date: 04/1/15

uluru inc (OXX1) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $335.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $200.0K
Vice President of Polymer Drug Delivery
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2014.

uluru inc (OXX1) Key Developments

ULURU Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

ULURU Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, total revenues were $294,648 compared to $101,980 a year ago, The increase of $193,000 in revenues is attributable to an increase in Altrazeal product sales primarily reflecting a significant shipment to Middle East distributors, and reflects the revised pricing resulting from the recently announced acquisition of Altrazeal Trading GmbH. Operating loss was $632,668 compared to $773,445 a year ago. Loss before income taxes was $738,273 compared to $868,291 a year ago. Net loss allocable to common shareholders was $738,273 or $0.03 basic and diluted per share compared to $868,291 or $0.04 basic and diluted per share a year ago.

ULURU Inc., Q1 2015 Earnings Call, May 18, 2015

ULURU Inc., Q1 2015 Earnings Call, May 18, 2015

ULURU Inc. Announces the Settlement of Outstanding Litigation with Inter-Mountain Capital Corporation

ULURU Inc. announced that they have entered a settlement agreement with Inter-Mountain Capital Corporation to resolve the outstanding litigation associated with a warrant exercise. Under the terms of the settlement, Uluru issued Inter-Mountain 361,516 shares of common stock, issued an unsecured promissory note for $550,000, and a five year warrant to purchase 194,118 shares of common stock at an exercise price of $0.85 per share. Repayment of the promissory note commences 120 days after the issuance of the note, which can be paid in cash or shares of common stock at the company's election. The complaint filed by Inter-Mountain originally claimed 782,234 shares of common stock for the exercise of the warrant and liquidated damages.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXX1:GR €0.19 EUR 0.00

OXX1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $161.04 USD +1.45
Smith & Nephew PLC 1,165 GBp +25.00
View Industry Companies

Industry Analysis


Industry Average

Valuation OXX1 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.5x
Price/Book 6.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULURU INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at